Idea Exchange Meeting with Helen Evans (GAVI Alliance CEO), Suzuki Shigeharu (Chairman of Daiwa Securities Group), and HGPI
date : 6/3/2011
Although Febuarys Global Health Forum had a very broad theme, it was agreed that Japan will continue to confront global health issues using public funds and market mechanisms that use private funds. It was widely agreed that the significance of private funding needs to be expanded.
Since 2008, a total of 15 billion dollars in vaccine bonds was purchased by Japanese citizens, which supported many GAVI alliance activities. Arranged by Daiwa, vaccine bonds are issued by The International Finance Facility for Immunization Company (IFFIm). IFFIm raises funds in the international capital markets that are used by the GAVI Alliance to save children’s lives and protect people’s health by increasing access to immunization in developing countries.
Evans commenced the meeting by expression her gratitude to the Japanese for their cooperation with The GAVI Alliance. Japanese citizens have proven, and can continue to prove, the importance of their participation in innovative financial mechanisms like the vaccine bonds. In the future, GAVI Alliance, alongside Japanese businesses and think tanks, hopes to further validate the importance of strong cooperation.
Exhibition date:2011-06-03
Top Research & Recommendations Posts
- [Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Announcement] Signs Health Policy Recommendations to the G7 by the C7 Global Health Working Group (March 30, 2026)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)



